| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Mrz―28 |
The reactivation of the various types of viruses following COVID-19 infection: a systematic review |
Maziar Naderi, Mohieddin Naderi, Mahboob Keramati Jamal, Vida Past, Arezoo Esmaeili, Aynaz Khabazian, Somayeh Hashemi Ali Abadi, Golbarg Saremi, Shima Asghari, Shadi Moghimi, Neda Parnianfard, Mina Parnianfard |
| 2 |
[GO] |
2025―Mrz―21 |
Neurofilament light chain as a biomarker for neurodegenerative changes in COVID-19 and clinical implications |
Yousef Rasmi, Yeganeh Farnamian, Marijana Markovic Boras, Nihal Inandiklioglu, Charles Adolfu Shirima, Ladan Jalali |
| 3 |
[GO] |
2025―Feb―24 |
Development and evaluation of MMIRA-CRISPR/Cas13a-MBQD assay for the detection of influenza A/B viruses and SARS-CoV-2 |
Ning Yang, Jun-Yan Ma, Qiao Qiao, Xiao-Juan Zhu, Tao Wu, Kang-Chen Zhao, Ying Chi, Ge Hu, Zi-Yang Hao, Lun-Biao Cui, Yi-Yue Ge |
| 4 |
[GO] |
2025―Feb―11 |
Spironolactone as an adjuvant treatment for COVID-19: a systematic review and meta-analysis |
Arman Shafiee, Mohammad Javad Amini, Mohammad Ali Rafiei, Amirhossein Akhondi, Kyana Jafarabady, Ghazale Molaverdi, Sayed-Hamidreza Mozhgani |
| 5 |
[GO] |
2025―Jan―09 |
COVID-19 treatment that contains ritonavir may interact with other drugs: a plain language summary |
Kaylen Brzozowski, Amy Puenpatom, Ebuwa Igho-Osagie, Marissa Grifasi Williams |
| 6 |
[GO] |
2024―Dez―16 |
Implication of iron overload in COVID-19 pathogenesis and long COVID: a mechanistic review |
Bijita Bhowmick, Anirban Roy, Avipsha Sarkar, Tanusree Ghorai, Debadatta Nayak, Satadal Das |
| 7 |
[GO] |
2024―Nov―16 |
Exploring plasma expression levels of miR-200c-3p, miR-150, and miR-155 in SARS-CoV-2 positive and negative subjects |
Ehsan Kakavandi, Somayeh Shatizadeh Malekshahi, Kaveh Sadeghi, Mohammad Shayestehpour, Abbas Rahimi Foroushani, Talat Mokhtari-Azad, Nazanin-Zahra Shafiei-Jandaghi, Jila Yavarian |
| 8 |
[GO] |
2024―Sep―25 |
Transitioning from Crisis to Control: Reviewing Antiviral Agents Targeting Pandemic Viruses |
Deepali Nahar, Sayali Ayare, Meena Kanyalkar |
| 9 |
[GO] |
2024―Aug―12 |
The treatment of COVID-19: lessons learned and future directions |
Michael A Cenname, Matthew W McCarthy |
| 10 |
[GO] |
2024―Jun―17 |
Genomic epidemiology and phylogeographic dynamics of SARS-CoV-2 during the sixth wave and post-sixth wave in Pakistan |
Zunera Jamal, Syed Adnan Haider, Muhammad Ammar, Zaira Rehman, Afreenish Amir, Aamer Ikram, Muhammad Salman, Massab Umair |
| 11 |
[GO] |
2024―Jun―17 |
Remarkable proliferative ability of the Omicron variant in the nasal cavity compared to other SARS-CoV-2 variants |
Hirokazu Yamagishi, Daisuke Tamura, Yuji Morisawa, Takashi Mato, Shin Nunomiya, Toshihiro Tajima, Hitoshi Osaka |
| 12 |
[GO] |
2024―Jun―05 |
Resistance analysis in the phase III COMET-TAIL study: treatment of COVID-19 with intramuscular or intravenous sotrovimab |
Maria L Agostini, Gretja Schnell, Julia di Iulio, Anita Kohli, Adrienne E Shapiro, Elias H Sarkis, Naomi Givens, Amanda Peppercorn, Andrew Skingsley, Leah A Gaffney, Melissa Aldinger, Christy M Hebner, Andrea L Cathcart |
| 13 |
[GO] |
2024―Mai―18 |
Coping with the Third wave of the COVID-19 Pandemic in Africa: Implications for an Improved Outbreak Response |
Olayinka Stephen Ilesanmi, Francesco Chirico, Aanuoluwapo Adeyimika Afolabi, Gabriella Nucera |
| 14 |
[GO] |
2024―Apr―12 |
RNAi-mediated inhibition of SARS-CoV-2: applications and challenges |
Debosmita Sanyal, Binay Chaubey |
| 15 |
[GO] |
2024―Mrz―26 |
Exploration of the cross-immunity between SARS-CoV and SARS-CoV-2 in mice |
Shuhui Wang, Li Ren, Ying Liu, Xiuli Shen, Yanling Hao, Yiming Shao |
| 16 |
[GO] |
2024―Mrz―18 |
Direct virus capture assay for label-free detection of SARS-CoV-2 virions using laser microscopy |
Alessandro Pennesi, Guglielmo Ferrari, Federica Giardina, Sara Piselli, Roberto Lo Savio, Adolfo Carloni, Stefania Paolucci, Fausto Baldanti |
| 17 |
[GO] |
2024―Feb―26 |
Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir |
Roberta Monardo, Andrea Mastrangelo, Laura Galli, Alessandro Tomelleri, Vincenzo Spagnuolo, Chiara Oltolini, Giacomo Ponta, Corrado Campochiaro, Giulio Cavalli, Lorenzo Dagna, Fabio Ciceri, Paola Cinque, Paolo Scarpellini, Antonella Castagna, Marco Ripa |
| 18 |
[GO] |
2024―Feb―09 |
Developing a risk prediction model for COVID-19 infection in heart transplant recipients using artificial intelligence |
Shriya Sharma, Nora Menon, Jose Ruiz, Caitlyn Luce, Lisa Brumble, Anirban Bhattacharya, Rohan Goswami |
| 19 |
[GO] |
2024―Feb―05 |
Preliminary application of a coronavirus pseudovirus system |
Xiaoli Tao, Tengfei Li, Baojun He, Wei Zhao, Siman Hu, Zhuping Ma, Lvyin Sun, Runlin Li, Like Luo, Yonggang Li |
| 20 |
[GO] |
2023―Dez―21 |
Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study |
Sambhavi Subramanian, Gretja Schnell, Julia di Iulio, Anil K Gupta, Adrienne E Shapiro, Elias H Sarkis, Amanda Lopuski, Amanda Peppercorn, Melissa Aldinger, Christy M Hebner, Andrea L Cathcart |
| 21 |
[GO] |
2023―Dez―19 |
Effect of the COVID-19 pandemic on the reporting of Crimean-Congo hemorrhagic fever |
Mohammad Hassan Pouriayevali, Ehsan Mostafavi, Mehdi Fazlalipour, Tahmineh Jalali, Sahar Khakifirouz, Seyed Dawood Mosavi-Nasab, Mostafa Salehi-Vaziri |
| 22 |
[GO] |
2023―Nov―07 |
Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study |
Shahd A Mohammedain, Saif Badran, AbdelNaser Y Elzouki, Halla Salim, Ayesha Chalaby, MYA Siddiqui, Yehia Y Hussein, Hanan Abdul Rahim, Lukman Thalib, Mohammed Fasihul Alam, Daoud Al-Badriyeh, Sumaya Al-Maadeed, Suhail AR Doi |
| 23 |
[GO] |
2023―Nov―07 |
Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection |
Soumik Goswami, Jayita Pal Chowdhury |
| 24 |
[GO] |
2023―Nov―01 |
Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY) |
Arantxa Horga, Rebecca Saenz, Gürdal Yilmaz, Abraham Simón-Campos, Keith Pietropaolo, William J Stubbings, Neil Collinson, Laura Ishak, Barbara Zrinscak, Bruce Belanger, Catherine Granier, Kai Lin, Aeron C Hurt, Xiao-Jian Zhou, Steffen Wildum, Janet Hammond |
| 25 |
[GO] |
2023―Okt―26 |
In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes |
Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari |
| 26 |
[GO] |
2023―Okt―18 |
Genotoxicity: a neglected but potentially critical aspect of adenoviral COVID-19 vaccines |
Alireza Mardomi, Tahoora Mousavi, Farahnoosh Farnood, Hamid Tayebi Khosroshahi |
| 27 |
[GO] |
2023―Sep―19 |
‘The end’ - or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 subvariants |
Farid Rahimi, Mohammad Darvishi, Amin Talebi Bezmin Abadi |
| 28 |
[GO] |
2023―Sep―11 |
Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy |
Mona Fani, Maryam Moossavi, Hasan Bakhshi, Abozar Nasiri Jahrodi, Mohammad Reza Khazdair, Amir Hossein Zardast, Shokouh Ghafari |
| 29 |
[GO] |
2023―Jul―28 |
Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age |
CB Creech, E Anderson, V Berthaud, I Yildirim, AM Atz, I Melendez Baez, D Finkelstein, P Pickrell, J Kirstein, C Yut, R Blair, RA Clifford, M Dunn, JD Campbell, DC Montefiori, JE Tomassini, X Zhao, W Deng, H Zhou, D Ramirez Schrempp, K Hautzinger, B Girard, K Slobod, R McPhee, R Pajon, R Das, JM Miller, S Schnyder Ghamloush |
| 30 |
[GO] |
2023―Jul―13 |
Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19 |
Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eybpoosh, Delaram Doroud, Iraj Ahmadi, Enayat Anvari, Mohammadreza Aghasadeghi, Abolfazl Fateh |
| 31 |
[GO] |
2023―Jun―24 |
Design and generation of mRNAs encoding conserved regions of SARS-CoV-2 ORF1ab for T cell-mediated immune activation |
Cao Minh Nguyen, Bac An Luong, Thu Thuy Thi Tran, Hoai Nghia Nguyen, Le Son Tran |
| 32 |
[GO] |
2023―Jun―23 |
Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19 |
Arantxa Horga, Daniel R. Kuritzkes, John J. Kowalczyk, Keith Pietropaolo, Bruce Belanger, Kai Lin, Kristen Perkins, Janet Hammond |
| 33 |
[GO] |
2023―Jun―16 |
COVID-19 post vaccination neuronal adverse events: probable mechanisms and treatment possibilities |
Abdul Mannan Baig, Joachim Gerlach, Prakash Salunke, Rachel Jessey, Robin Rose |
| 34 |
[GO] |
2023―Jun―16 |
Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity |
Joachim Gerlach, Abdul Mannan Baig |
| 35 |
[GO] |
2023―Jun―07 |
Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach |
Adrianne M Lima, Adson A de Souza, Jackson L Amaral, Valder N Freire, Pedro F N Souza, Hermógenes D de Oliveira |
| 36 |
[GO] |
2023―Jun―01 |
CpG 684: an effective adjuvant for the inactivated COVID-19 vaccine in mice |
Jiandong Liu, Tianle Cang, Congli Jiang, Kelei Li, Siyuan Liu, Haixin Wang, Meirong Wang, Yan Chen, Yan Shao, Jiankai Liu |
| 37 |
[GO] |
2023―Jun―01 |
Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins |
Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari |
| 38 |
[GO] |
2023―Mai―22 |
In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease |
Yousef A Abdelrady, Naeem Mahmood Ashraf, Arslan Hamid, Hayam S Thabet, Asmaa M Sayed, Shimaa H Salem, Emad HM Hassanein, Ahmed M Sayed |
| 39 |
[GO] |
2023―Mai―22 |
Identification of host factors that bind to the 5′ end of the MERS-CoV RNA genome |
Bader Y Alhatlani, Waleed Aljabr, Fatimah S Alhamlan, Ahmad Almatroudi, Mohd Azam, Mansour Alsaleem, Khaled S Allemailem |
| 40 |
[GO] |
2023―Apr―17 |
Efficiency rating of SG Diagnostics COVID-19 antigen rapid test kit |
Francesco Chirico, Murat Yıldırım, Tomasz Dzieciatkowski, Marek Dabrowski, Marek Malysz, Marcin Madziala, Milosz Jaroslaw Jaguszewski, Karol Bielski, Gabriella Nucera, Krzysztof J Filipiak, Lukasz Szarpak |
| 41 |
[GO] |
2023―Apr―11 |
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes |
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu |
| 42 |
[GO] |
2023―Apr―11 |
In silico analysis of ACE2 from different animal species provides new insights into SARS-CoV-2 species spillover |
Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Dyane Rocha Aragão, Expedito Maia Diógenes, Emerson Lucena da Silva, Jackson Lima Amaral, Valder Nogueira Freire, Débora de Souza Collares Maia Castelo-Branco, Raquel Carvalho Montenegro |
| 43 |
[GO] |
2023―Apr―06 |
The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on the stability of RBD-ACE2 complex |
Mykyta Peka, Viktor Balatsky |
| 44 |
[GO] |
2023―Apr―04 |
Evidence-based policies in public health to address COVID-19 vaccine hesitancy |
Francesco Chirico, Jaime A Teixeira da Silva |
| 45 |
[GO] |
2023―Mrz―14 |
Natural killer cells in COVID-19: from infection, to vaccination and therapy |
Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi |
| 46 |
[GO] |
2023―Mrz―09 |
A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease? |
Arman Shafiee, Mohammad Mobin Teymouri Athar, Sayed-Hamidreza Mozhgani |
| 47 |
[GO] |
2023―Mrz―06 |
Two sides of the same coin: the N-terminal and the receptor binding domains of SARS-CoV-2 Spike |
Massimo Ciccozzi, Stefano Pascarella |
| 48 |
[GO] |
2023―Feb―20 |
HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors |
William Lemieux, Josée Perreault, Gabriel André Leiva-Torres, Nadia Baillargeon, Jessica Constanzo Yanez, Marie-Claire Chevrier, Lucie Richard, Antoine Lewin, Patrick Trépanier |
| 49 |
[GO] |
2023―Feb―03 |
SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening |
Jiahui Wu, Zhiqiang Chen, Xue Han, Qiaoqiao Chen, Yintao Wang, Tingting Feng |
| 50 |
[GO] |
2023―Jan―27 |
Is the emergence of the zoonotic Langya virus amidst COVID-19 and monkeypox a cause for concern? |
Chandan Kumar Thakur, Jog Bahadur Adhikari, Nitin Gupta, Prakash Ghimire, Meghnath Dhimal |
| 51 |
[GO] |
2023―Jan―19 |
Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19 |
Fangyuan Long, Shiheng Zhu, Zeguang Wang, Shungeng Zhang, Jinlong He, Xinbin Ge, Jun Ning |
| 52 |
[GO] |
2023―Jan―16 |
Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old |
Robert W Frenck, Nicola P Klein, Nicholas Kitchin, Alejandra Gurtman, Judith Absalon, Stephen Lockhart, John L Perez, Emmanuel B Walter, Shelly Senders, Ruth Bailey, Kena A Swanson, Hua Ma, Xia Xu, Kenneth Koury, Warren V Kalina, David Cooper, Timothy Jennings, Donald M Brandon, Stephen J Thomas, Özlem Türeci, Dina B Tresnan, Susan Mather, Philip R Dormitzer, Uğur Şahin, Kathrin U Jansen, William C Gruber |
| 53 |
[GO] |
2023―Jan―10 |
Diagnosing COVID-19: diagnostic importance of detecting E gene of the SARS-CoV-2 genome |
Iva Barjaktarović, Jelena Stojčević Maletić, Nataša Vučinić, Aleksandra Milutinović, Maja Grujičić, Velibor Čabarkapa |
| 54 |
[GO] |
2023―Jan―09 |
The prevalence of deep vein thrombosis and associated risk factors among patients with COVID-19 in the North of Iran |
Maryam Yaseri, Seyyedeh Sahereh Mortazavi Khatibani, Elahe Ghorbani Totkaboni, Haniyeh Sadat Fayazi |
| 55 |
[GO] |
2022―Nov―25 |
Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older |
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Fernando P Polack, Cristiano Zerbini, Ruth Bailey, Kena A Swanson, Xia Xu, Satrajit Roychoudhury, Kenneth Koury, Salim Bouguermouh, Warren V Kalina, David Cooper, Robert W Frenck, Laura L Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Qi Yang, Paul Liberator, Dina B Tresnan, Susan Mather, Philip R Dormitzer, Uğur Şahin, William C Gruber, Kathrin U Jansen |
| 56 |
[GO] |
2022―Okt―22 |
Variation analysis of SARS-CoV-2 complete sequences from Iran |
Jale Moradi, Parnia Moradi, Amir H Alvandi, Ramin Abiri, Mohsen Moghoofei |
| 57 |
[GO] |
2022―Okt―17 |
Blood types (ABO/Rhesus) and SARS-CoV-2 infection: a retrospective, cross-sectional study in 2828 healthcare workers |
Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Melike Nur Ozcelik, Hulya Yilmaz-Ak, Muge Topal, Sumeyye Ustun-Al, Filiz Pehlivanoglu, Gonul Sengoz |
| 58 |
[GO] |
2022―Sep―26 |
Reinfection and reactivation of SARS-CoV-2 |
Razieh Dowran, Amirmasoud Rayati Damavandi, Talat Mokhtari Azad |
| 59 |
[GO] |
2022―Sep―26 |
Rapid antigen test for SARS-CoV-2: results of validation and use in real life |
Irena Grmek Kosnik, Urska Dermota, Andrej Golle, Tjasa Zohar Cretnik |
| 60 |
[GO] |
2022―Sep―23 |
Similarity between cutaneous reactions due to SARS-CoV-2 and its vaccinations |
Ömer Kutlu, Selami Aykut Temiz |
| 61 |
[GO] |
2022―Sep―16 |
Relevance of cycle threshold values in mass screening by reverse-transcription-PCR during COVID-19 pandemic in Belgium: a decision-making support? |
Patrice Dufour, Henry Paridaens, Jean-Marc Senterre, Jean-Marc Minon |
| 62 |
[GO] |
2022―Sep―14 |
A plain language summary of the Janssen COVID-19 vaccine effectiveness and safety as a single dose and with a booster |
Frank Struyf, Jerald Sadoff, Karin Hardt, Macaya Douoguih |
| 63 |
[GO] |
2022―Aug―31 |
Sudden onset of decreased vision following Delta variant of SARS-CoV-2 infection: a case report |
Akram Sadat Ahmadi, Nazanin Zahra Shafiei-Jandaghi, Kaveh Sadeghi, Mohammadreza Salehi, Talat Mokhtari-Azad, Jila Yavarian |
| 64 |
[GO] |
2022―Aug―08 |
Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study |
Fatemeh Sana Askari, Mohsen Ebrahimi, Jabbar Parhiz, Mina Hassanpour, Alireza Mohebbi, Abbas Mirshafiey |
| 65 |
[GO] |
2022―Aug―02 |
Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy |
Alpo Vuorio, Petri T Kovanen, Frederick Raal |
| 66 |
[GO] |
2022―Aug―02 |
Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations |
Kundan Solanki, Sajjan Rajpoot, Ashutosh Kumar, Kam Y J Zhang, Tomokazu Ohishi, Nik Hirani, Khandu Wadhonkar, Pramod Patidar, Qiuwei Pan, Mirza S Baig |
| 67 |
[GO] |
2022―Jul―22 |
Tripartite communication in COVID-19 infection: SARS-CoV-2 pathogenesis, gut microbiota and ACE2 |
Sara Ahmadi Badi, Shohreh Khatami, Seyed Davar Siadat |
| 68 |
[GO] |
2022―Jul―19 |
A rare case of septic pulmonary embolism in co-existence with infective endocarditis and COVID-19 |
Yusuf Emre Ozdemir, Adile Sevde Demir, Meryem Sahin Ozdemir, Busra Mavi, Can Ozen, Hayat Kumbasar Karaosmanoglu |
| 69 |
[GO] |
2022―Jul―19 |
Nothing in SARS-CoV-2 makes sense except in the light of RNA modification? |
Mingmei Zhao, Chunxiao Li, Yu Dong, Xuekun Wang, Wenqing Jiang, Yaogang Chen |
| 70 |
[GO] |
2022―Jul―01 |
Molecular and antigen tests, and sample types for diagnosis of COVID-19: a review |
Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan |
| 71 |
[GO] |
2022―Jul―01 |
SARS-CoV-2 and its repercussive effect on reproductive health: recent trends |
Sukanth Kumar Enmozhi, Jerrine Joseph |
| 72 |
[GO] |
2022―Jun―28 |
IGA nephropathy and spinal epidural abscess after COVID-19 infection: a case report |
Burak Göre, Ezgi Coşkun Yenigün, Şimal Köksal Cevher, Emre Çankaya, Numan Aydın, Fatih Dede |
| 73 |
[GO] |
2022―Jun―16 |
A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program |
Vijay Rani Rajpal, Shashi Sharma, Deepmala Sehgal, Apekshita Singh, Avinash Kumar, Samantha Vaishnavi, Mugdha Tiwari, Hemal Bhalla, Shailendra Goel, Soom Nath Raina |
| 74 |
[GO] |
2022―Jun―15 |
Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience |
Hakan Apaydin, Abdulsamet Erden, Serdar C Güven, Berkan Armağan, Özlem Karakaş, Bahar Özdemir, Bünyamin Polat, Mehmet Akif Eksin, Ahmet Omma, Orhan Kucuksahin |
| 75 |
[GO] |
2022―Jun―08 |
Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus |
Gulten Tuncel, Mahmut Cerkez Ergoren, Buket Baddal, Pinar Tulay, Cenk Serhan Ozverel, Emrah Guler, Huseyin Kaya Suer, Murat Sayan, Tamer Sanlidag |
| 76 |
[GO] |
2022―Jun―03 |
Mapping of SARS-CoV-2 spike protein evolution during first and second waves of COVID-19 infections in India |
Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, Samantha Vaishnavi, Apekshita Singh, Deepmala Sehgal, Mughdha Tiwari, Shailendra Goel, Soom Nath Raina |
| 77 |
[GO] |
2022―Jun―03 |
Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis |
Fangwen Zhou, Jiawen Deng, Kiyan Heybati, Qi Kang Zuo, Saif Ali, Wenteng Hou, Chi Yi Wong, Harikrishnaa Ba Ramaraju, Oswin Chang, Thanansayan Dhivagaran, Zachary Silver |
| 78 |
[GO] |
2022―Mai―09 |
Evaluation of SARS-CoV-2 genome detection by real-time PCR assay using pooled specimens |
Forough Tavakoli, Jila Yavarian, Nazanin Zahra Shafiei Jandaghi, Kaveh Sadeghi, Nastaran Ghavami, Vahid Salimi, Talat Mokhtari-Azad |
| 79 |
[GO] |
2022―Apr―26 |
Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent |
Meng Zhang, Yixin Gong, Shunchang Jiao |
| 80 |
[GO] |
2022―Apr―19 |
Need for more robust research on the effectiveness of masks in preventing COVID-19 transmission |
Jingjing Nie, Linna Kang, Yaya Pian, Jihong Hu |
| 81 |
[GO] |
2022―Apr―19 |
Toll-like receptor 4 in COVID-19: friend or foe? |
Suprabhat Mukherjee |
| 82 |
[GO] |
2022―Apr―11 |
Evaluation of rapid antigen detection kits for detection of SARS-CoV-2 B.1.617.2 virus |
Gannon CK Mak, Stephen SY Lau, Kitty KY Wong, Nancy LS Chow, Chi-Shan Lau, Edman TK Lam, Ken HL Ng, Rickjason CW Chan |
| 83 |
[GO] |
2022―Apr―05 |
Reviewing findings on the polypeptide sequence of the SARS-CoV-2 S-protein to discuss the origins of the virus |
Alberto Maria Cattaneo |
| 84 |
[GO] |
2022―Apr―04 |
In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery |
Amira R Khattab, Mohamed Teleb |
| 85 |
[GO] |
2022―Mrz―21 |
Can anti-parasitic drugs help control COVID-19? |
Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, Zahra Gharari, Vahid Asghariazar, Arash Abdolmaleki, Somayeh Matin, Soheila Molaei |
| 86 |
[GO] |
2022―Mrz―17 |
A community call to action: mitigating COVID pandemic’s impact on mental health |
Wahid Ullah, Muhammad Ilyas, Mukhtar Alam, Jong Bhak, Peter J Tonellato |
| 87 |
[GO] |
2022―Mrz―08 |
Massive third wave of COVID-19 outbreak in Bangladesh: a co-epidemic of dengue might worsen the situation |
Popy Devnath, Md. Jamal Hossain, Talha Bin Emran, Saikat Mitra |
| 88 |
[GO] |
2022―Mrz―01 |
Airborne transmission of SARS-CoV-2 disease (COVID-19) |
Mohammad K Parvez, Shama Parveen |
| 89 |
[GO] |
2022―Feb―21 |
A nomogram predicting the severity of COVID-19 based on initial clinical and radiologic characteristics |
Hanfei Zhang, Feiyang Zhong, Binchen Wang, Meiyan Liao |
| 90 |
[GO] |
2022―Feb―11 |
Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report |
Alireza Ala, Solomon Habtemariam, Samad Shams Vahdati, Aysa Rezabakhsh |
| 91 |
[GO] |
2022―Feb―10 |
Research progresses in vertical transmission of SARS-CoV-2 among infants born to mothers with COVID-19 |
Zhoujie Peng, Jing Zhang, Yuan Shi, Ming Yi |
| 92 |
[GO] |
2022―Feb―10 |
Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19 |
Serdar Can Güven, Hakan Apaydın, Bahar Özdemir, Berkan Armağan, İhsan Ateş, Abdulsamet Erden, Orhan Küçükşahin, Ahmet Omma |
| 93 |
[GO] |
2022―Feb―10 |
Computed tomography evaluation of pancreatic steatosis: correlation with COVID-19 prognosis |
Serkan Guneyli, Hakan Dogan, Omer Tarik Esengur, Hur Hassoy |
| 94 |
[GO] |
2022―Jan―31 |
Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis |
Jiawen Deng, Fangwen Zhou, Wenteng Hou, Kiyan Heybati, Saif Ali, Oswin Chang, Zachary Silver, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Chi Yi Wong, Qi Kang Zuo, Elizabeth Lapshina, Madeline Mellett |
| 95 |
[GO] |
2022―Jan―12 |
Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses |
Jean-François Rossignol |
| 96 |
[GO] |
2022―Jan―12 |
Anterior ischemic optic neuropathy as a rare manifestation of COVID-19: a case report |
Khodayar Golabchi, Alireza Rezaee, Davood Aghadoost, Maryam Hashemipour |
| 97 |
[GO] |
2021―Dez―15 |
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19 |
Nigel A Makoah, Thomas Tipih, Matefo M Litabe, Mareza Brink, Joseph B Sempa, Dominique Goedhals, Felicity J Burt |
| 98 |
[GO] |
2021―Dez―15 |
Identifying asymptomatic cases during the mass COVID-19 vaccination campaign: insights and implications for policy makers |
Francesco Chirico, Gabriella Nucera, Olayinka Ilesanmi, Aanuoluwapo Afolabi, Michal Pruc, Lukasz Szarpak |
| 99 |
[GO] |
2021―Dez―15 |
Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients |
Cameron A Brown, Megan H Amerson-Brown, Aliza Rahman, Charity R Webb, Ila R Singh, James J Dunn |
| 100 |
[GO] |
2021―Dez―06 |
Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA |
Gerard Milano, Jocelyn Gal, Anne Creisson, Emmanuel Chamorey |
| 101 |
[GO] |
2021―Dez―03 |
Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis |
Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Saif Ali, Qi Kang Zuo, Wenteng Hou, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Oswin Chang, Chi Yi Wong, Zachary Silver |
| 102 |
[GO] |
2021―Nov―26 |
A brief review on DNA vaccines in the era of COVID-19 |
Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, Fereshte Hazrati, Rasoul Mirzaei, Bagher Amirheidari, Hamid Tanzadehpanah, Sajad Karampoor, Sima Kazemi, Bahram Yavari, Hanie Mahaki, Mohsen Safaei, Fatemeh Rahbarizadeh, Pouria Samadi, Yaghoub Ahmadyousefi |
| 103 |
[GO] |
2021―Nov―26 |
Non-SARS, non-MERS human coronavirus infections and risk of Kawasaki disease: a meta-analysis |
Pratap Kumar Patra, Rashmi Ranjan Das, Aaqib Zaffar Banday, Mini Singh, Kapil Goyal, Ankur Kumar Jindal, Surjit Singh |
| 104 |
[GO] |
2021―Nov―26 |
Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 symptoms in Iran |
Mehran Akbari, Mojtaba Didehdar, Mohsen Nazari, Davood Azadi |
| 105 |
[GO] |
2021―Nov―12 |
Detection and predictors of anti-SARS-CoV-2 antibody levels in COVID-19 patients at 8 months after symptom onset |
Jing Guo, Li Li, Qian Wu, Hongwei Li, Yajie Li, Xinwei Hou, Fangfei Yang, Zhonghua Qin |
| 106 |
[GO] |
2021―Nov―12 |
Temporal variations of country-specific mutational profile of SARS-CoV-2: effect on vaccine efficacy |
Sayantan Laha, Raghunath Chatterjee |
| 107 |
[GO] |
2021―Nov―04 |
The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic |
Farid Rahimi, Negin Kamali, Amin Talebi Bezmin Abadi |
| 108 |
[GO] |
2021―Nov―04 |
In-hospital clinical complications of COVID-19: a brief overview |
Kevin John John, Jemimah Nayar, Ajay Kumar Mishra, Vijairam Selvaraj, Mohammad Saud Khan, Amos Lal |
| 109 |
[GO] |
2021―Nov―04 |
The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants |
Farid Rahimi, Amin Talebi Bezmin Abadi |
| 110 |
[GO] |
2021―Nov―04 |
SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system |
Tariq Khan, Syed Muhammad Jamal |
| 111 |
[GO] |
2021―Okt―29 |
The international treaty for pandemic preparedness and response: same story, different times? |
Dominique Vervoort, Xiya Ma, Alia Sunderji, Hloni Bookholane |
| 112 |
[GO] |
2021―Okt―19 |
Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity |
Anthony Fata, Georges Jabbour, Hampig Kourie, Marianne Zoghbi, Elia Kassouf, Antoine Zoghbi |
| 113 |
[GO] |
2021―Okt―14 |
Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic |
Habib Jmii, Hakima Gharbi-Khelifi, Raouia Assaoudi, Mahjoub Aouni |
| 114 |
[GO] |
2021―Okt―08 |
Computed tomography-positive, SARS-CoV-2 RNA-negative symptomatic contacts of COVID-19 patients: what are their nature and implications? |
Lei Huang |
| 115 |
[GO] |
2021―Okt―08 |
A case series of pediatric COVID-19 with complicated symptoms in Iran |
Fatemeh Cheraghali, Leila Barati, Dayan Amanian, Lobat Shahkar, Maryam Najafinejad, Hamed Naziri, Somayeh Shahabi, Alijan Tabarraei, Alireza Tahamtan |
| 116 |
[GO] |
2021―Sep―22 |
Association between blood groups and COVID-19 outcome in Iranian patients |
Ali Asghar Ayatollahi, Bahman Aghcheli, Abolfazl Amini, Hasan Nikbakht, Parastoo Ghassemzadehpirsala, Emad Behboudi, Abdolhalim Rajabi, Alireza Tahamtan |
| 117 |
[GO] |
2021―Sep―21 |
High-value laboratory testing for hospitalized COVID-19 patients: a review |
Daniela Cihakova, Michael B Streiff, Steven P Menez, Teresa K Chen, Nisha A Gilotra, Erin D Michos, Kieren A Marr, Andrew H Karaba, Matthew L Robinson, Paul W Blair, Maria V Dioverti, Wendy S Post, Andrea L Cox, Annukka A R Antar |
| 118 |
[GO] |
2021―Sep―10 |
Fast evolution of SARS-CoV-2 driven by deamination systems in hosts |
Yanping Zhang, Wen Jiang, Yan Li, Xiaojie Jin, Xiaoping Yang, Pirun Zhang, Wenqing Jiang, Bin Yin |
| 119 |
[GO] |
2021―Sep―02 |
Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-19 |
Karuna M Das, Rajvir Singh, Sandeep Subramanya, Shreesh Kumar Ojha, Taleb Almansoori, Dilip Gokhale, Jamal Aldeen Alkoteesh |
| 120 |
[GO] |
2021―Sep―02 |
mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors |
Emre Yekedüz, Rüveyda Ayasun, Elif Berna Köksoy, Güngör Utkan, Yüksel Ürün, Hakan Akbulut |
| 121 |
[GO] |
2021―Aug―09 |
Harnessing immunological targets for COVID-19 immunotherapy |
Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu |
| 122 |
[GO] |
2021―Jul―29 |
Independent and incremental prognostic value of D-dimer in hospitalized COVID-19 patients |
Gerald Chi, Sahar Memar Montazerin, Jane J Lee |
| 123 |
[GO] |
2021―Jul―20 |
Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation |
Claudia Cava, Gloria Bertoli, Isabella Castiglioni |
| 124 |
[GO] |
2021―Jul―20 |
An overview of sex hormones in relation to SARS-CoV-2 infection |
Marzieh Saei Ghare Naz, Mojdeh Banaei, Sareh Dashti, Fahimeh Ramezani Tehrani |
| 125 |
[GO] |
2021―Jul―20 |
In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database |
Eldar Muhtar, Mengyang Wang, Haimei Zhu |
| 126 |
[GO] |
2021―Jul―13 |
Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study |
Ajita Pandey, Mohit Sharma |
| 127 |
[GO] |
2021―Jul―13 |
Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective |
Shafi Mahmud, Abdo A Elfiky, Al Amin, Sumon Chandro Mohanto, Ekhtiar Rahman, Uzzal Kumar Acharjee, Abu Saleh |
| 128 |
[GO] |
2021―Jul―08 |
Association of anemia and COVID-19 in hospitalized patients |
Chong Chen, Wenhui Zhou, Wenliang Fan, Xianying Ning, Shuai Yang, Ziqiao Lei, Chuansheng Zheng |
| 129 |
[GO] |
2021―Jul―06 |
Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 2019 |
Hanqing Liu, Zhouru Ruan, Ziwei Yin, Dan Wu, Hong Zhu |
| 130 |
[GO] |
2021―Jun―30 |
Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer |
Roy Chebel, Chris Labaki, Maria Farhat, Joseph Kattan |
| 131 |
[GO] |
2021―Jun―22 |
The COVID-19 pandemic: an increased risk of rheumatoid arthritis |
Archana Tripathy, Nitish Swain, Bhawna Gupta |
| 132 |
[GO] |
2021―Jun―22 |
V483A: an emerging mutation hotspot of SARS-CoV-2 |
Omar Ashwaq, Pratibha Manickavasagam, SK Manirul Haque |
| 133 |
[GO] |
2021―Jun―22 |
Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates |
Liangyu Peng, Suliman Khan, Ashaq Ali, Saeed Ahmed, Liaqat Ali, Guang Han, Yang Jing |
| 134 |
[GO] |
2021―Jun―01 |
Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery |
Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, Mohsen Ebrahimi, Zahra Najafimemar |
| 135 |
[GO] |
2021―Mai―24 |
Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series |
Ran Cui, Ying Zhu, Yulan Wang, Xiao-Hua Chen, Qiang Li, Sheng-Ming Dai, Qiang Tong |
| 136 |
[GO] |
2021―Mai―19 |
Natural selection on synonymous mutations in SARS-CoV-2 and the impact on estimating divergence time |
Yuanyuan Yu, Yan Li, Yu Dong, Xuekun Wang, Chunxiao Li, Wenqing Jiang |
| 137 |
[GO] |
2021―Mai―19 |
SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses |
Andrew P Rice, Jason T Kimata |
| 138 |
[GO] |
2021―Mai―12 |
Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission |
Emin Gemcioglu, Mehmet Davutoglu, Ramis Catalbas, Berkan Karabuga, Enes Kaptan, Adalet Aypak, Ayse K Kalem, Mustafa Özdemir, Necati Y Yeşilova, Emra A Kalkan, Musa Civak, Orhan Kücüksahin, Abdulsamet Erden, Ihsan Ates |
| 139 |
[GO] |
2021―Apr―26 |
An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: an in silico approach |
Sina Zoghi, Hossein Jafari Khamirani, Seyed Alireza Dastgheib, Mehdi Dianatpour, Alireza Ghaffarieh |
| 140 |
[GO] |
2021―Apr―22 |
HIV and COVID-19 pandemic collision: turning challenges into opportunity |
Stefano Rusconi, Laura Pezzati, Tiziana Formenti, Andrea Giacomelli |
| 141 |
[GO] |
2021―Apr―21 |
Investigation of the relationship between inherited thrombophilia and novel coronavirus pneumonia |
Aslihan Kiraz, Seda Guzeldag, Esma Eren, Musa Goksu, Arslan Bayram |
| 142 |
[GO] |
2021―Apr―14 |
The initial infectious dose of SARS-CoV-2 and the severity of the disease: possible impact on the incubation period |
Hamid Tayebi Khosroshahi, Alireza Mardomi |
| 143 |
[GO] |
2021―Apr―07 |
Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients |
Jingping Cheng, Wanxin Liu, Siyang Chen, Xiafen Hu, Xiaochen Xiang, Zhongliang Cheng, Shaoqian Cai, Kaiwen Guo, Qiang Wang, Xiaoliu Liu, Qingming Wu |
| 144 |
[GO] |
2021―Apr―06 |
Xerostomia (dry mouth) in patients with COVID-19: a case series |
Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Fatemeh Atoof, Reza Mottaghi |
| 145 |
[GO] |
2021―Mrz―25 |
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach |
Abhigyan Choudhury, Nabarun C Das, Ritwik Patra, Manojit Bhattacharya, Pratik Ghosh, Bidhan C Patra, Suprabhat Mukherjee |
| 146 |
[GO] |
2021―Mrz―24 |
The role of miRNAs in COVID-19 disease |
Mona Fani, Milad Zandi, Saeedeh Ebrahimi, Saber Soltani, Samaneh Abbasi |
| 147 |
[GO] |
2021―Mrz―09 |
Erythema multiform-like lesions in a patient infected with SARS-CoV-2: a case report |
Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Reza Mottaghi |
| 148 |
[GO] |
2021―Mrz―08 |
Comparative sequence analysis of SARS-CoV-2 suggests its high transmissibility and pathogenicity |
Kartika Padhan, Mohammad K Parvez, Mohammed S Al-Dosari |
| 149 |
[GO] |
2021―Mrz―02 |
Computational guided approach for drug repurposing against SARS-CoV-2 |
Jigisha Anand, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma, Nishant Rai |
| 150 |
[GO] |
2021―Feb―24 |
Epidemiologic features and clinical course of COVID-19: a retrospective analysis of 19 patients in Germany |
Sara Elgamasy, Eman Elsayed Sakr, Mohamed Gomaa Kamel, Sherief Ghozy, Ghadeer Gamal Elsayed, Mostafa Mahmoud Fahmy, Ahmed Ghazy, Mohamed Maged Nagaty Ibrahim, Mostafa Ebraheem Morra |
| 151 |
[GO] |
2021―Feb―22 |
Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition |
Zaira Rehman, Ammad Fahim, Muhammad Faraz Bhatti |
| 152 |
[GO] |
2021―Feb―09 |
The long-quarantined case of COVID-19 with prolonged viral shedding and intermittent fever for more than 70 days |
Eijiro Yamada, Emi Ishida, Yasuyo Nakajima, Kazuhiko Horiguchi, Shunichi Matsumoto, Shuichi Okada, Wataru Kamitani, Masanobu Yamada |
| 153 |
[GO] |
2021―Feb―04 |
What is the intermediate host species of SARS-CoV-2? |
Thomas Friend, Justin Stebbing |
| 154 |
[GO] |
2021―Feb―03 |
SARS-CoV-2 direct real-time polymerase chain reaction testing in laboratories with shortage challenges |
Taghreed Alaifan, Asmaa Altamimi, Dalia Obeid, Turki Alshehri, Shaihana Almatrrouk, Ahmed Albarrag |
| 155 |
[GO] |
2021―Jan―28 |
Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran |
Hamed Fakhim, Elahe Nasri, Shima Aboutalebian, Sahar Gholipour, Mahnaz Nikaeen, Afsane Vaezi, Somayeh Mousavi, Sama Faramarzi, Armin Farhang, Shaghayegh Haghjooy Javanmard, Mehrdad Salahi, Ali Darakhshandeh, Kazem Ahmadikia, Hossein Mirhendi |
| 156 |
[GO] |
2021―Jan―26 |
Severe acute respiratory syndrome coronavirus 2 viral load in respiratory and feces specimens of children with coronavirus disease 2019 |
Xiang Ma, Liang Su, Lu Cheng, Zhaohua Zhang, Jing Sun, Miao Liu, Jing Wang, Xuemei Jiang, Yun Zhang, Yuling Han, Zhongfa Zhang, Zhongtao Gai |
| 157 |
[GO] |
2021―Jan―25 |
Clinical characteristics of outpatients and inpatients with COVID-19 in Bushehr: a report from the south of Iran |
Mohsen Keshavarz, Ahmad Tavakoli, Sareh Zanganeh, Mohammad Javad Mousavi, Katayoun Vahdat, Mehdi Mahmudpour, Iraj Nabipour, Amirhossein Darabi, Saeid Keshmiri |
| 158 |
[GO] |
2021―Jan―13 |
Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome |
María Magdalena Aguirre García, Javier Mancilla-Galindo, Mercedes Paredes-Paredes, Álvaro Zamudio Tiburcio, Nydia Ávila-Vanzzini |
| 159 |
[GO] |
2021―Jan―07 |
A new perspective of the chemistry and kinetics of inactivation of COVID -19 coronavirus aerosols |
Michael L Hitchman |
| 160 |
[GO] |
2020―Dez―24 |
Relationship between IL-6 and COVID-19: to be considered during treatment |
Hafize Seda Vatansever, Eda Becer |
| 161 |
[GO] |
2020―Dez―16 |
Pandemic response management framework based on efficiency of COVID-19 control and treatment |
Mustapha D Ibrahim, Fatima AS Binofai, Reem MM Alshamsi |
| 162 |
[GO] |
2020―Dez―15 |
Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19? |
Yashwant Kumar, Reena Yadav, Alka Bhatia |
| 163 |
[GO] |
2020―Nov―30 |
Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India |
Sameera Farah, Ashwin Atkulwar, Manas Ranjan Praharaj, Raja Khan, Ravikumar Gandham, Mumtaz Baig |
| 164 |
[GO] |
2020―Nov―26 |
The role of artificial intelligence in tackling COVID-19 |
Neelima Arora, Amit K Banerjee, Mangamoori L Narasu |
| 165 |
[GO] |
2020―Nov―26 |
Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh |
Nadim Sharif, Shuvra K Dey |
| 166 |
[GO] |
2020―Nov―04 |
LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic? |
Su M Metcalfe |
| 167 |
[GO] |
2020―Okt―28 |
A multiple-center clinical evaluation of a new real-time reverse transcriptase PCR diagnostic kit for SARS-CoV-2 |
Jing-Jing Guo, Yan-Hua Yu, Xue-Ying Ma, Ya-Nan Liu, Qian Fang, Pei Qu, Jie Guo, Jin-Li Lou, Ya-Jie Wang |
| 168 |
[GO] |
2020―Okt―27 |
Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection |
Rafeed Rahman Turjya, Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam |
| 169 |
[GO] |
2020―Okt―22 |
Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA |
Jing Wu, Xiao-ying Xia, He-lei Liu, Hong Xia, Wen-xiang Huang, Bei Jia, Feng-ying Peng |
| 170 |
[GO] |
2020―Okt―14 |
A comprehensive review about SARS-CoV-2 |
SK Manirul Haque, Omar Ashwaq, Abdulla Sarief, Abdul Kalam Azad John Mohamed |
| 171 |
[GO] |
2020―Okt―13 |
Implications of current and future approaches to coronavirus disease 2019 testing |
Rasheid Smith, Sean M Geary, Aliasger K Salem |
| 172 |
[GO] |
2020―Okt―08 |
The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19 |
Jaclyn Kelly Mann, Thumbi Ndung'u |
| 173 |
[GO] |
2020―Okt―08 |
In silico analysis of protein/peptide-based inhalers against SARS-CoV-2 |
Saad Salman, Fahad Hassan Shah, Maham Chaudhry, Muniba Tariq, Muhammad Yasir Akbar, Muhammad Adnan |
| 174 |
[GO] |
2020―Aug―26 |
Investigation of compatibility of severe acute respiratory syndrome coronavirus 2 reverse transcriptase-PCR kits containing different gene targets during coronavirus disease 2019 pandemic |
Figen Sarıgül, Osman Doluca, Sıla Akhan, Murat Sayan |
| 175 |
[GO] |
2020―Aug―26 |
Genetic and pathogenic characterization of SARS-CoV-2: a review |
Afsane Bahrami, Gordon A Ferns |
| 176 |
[GO] |
2020―Aug―18 |
A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases |
Niraja Soni, Puja Pai, Gurumurthy Raja Krishna Kumar, Venkatesh Prasad, Santanu Dasgupta, Bhaskar Bhadra |
| 177 |
[GO] |
2020―Aug―17 |
Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 2 |
Alireza Mohebbi, Fatemeh Sana Askari, Mohsen Ebrahimi, Mana Zakeri, Mohammad Yasaghi, Hanieh Bagheri, Naeme Javid |
| 178 |
[GO] |
2020―Aug―12 |
Thoughts on detecting tissue distribution of potential COVID-19 receptors |
Hongtao Tang, Xiaosheng Lu, Shuyan Qie, Jianing Xi |
| 179 |
[GO] |
2020―Jul―29 |
In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome |
Bader Y Alhatlani |
| 180 |
[GO] |
2020―Jul―27 |
COVID-19: studying the global pandemic - foreword |
Stefano Rusconi, Frederick G Hayden |
| 181 |
[GO] |
2020―Jul―27 |
Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future |
Mubasher Rehman, Isfahan Tauseef, Bibi Aalia, Sajid Hussain Shah, Muhammad Junaid, Kashif Syed Haleem |
| 182 |
[GO] |
2020―Jun―26 |
COVID-19 in homeless populations: unique challenges and opportunities |
Brian Conway, David Truong, Kelli Wuerth |
| 183 |
[GO] |
2020―Jun―12 |
COVID-19 and coronaviral hepatitis: evidence of collateral damage |
Mohammad K Parvez |
| 184 |
[GO] |
2020―Jun―12 |
Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection |
Jie Tan, Shousheng Liu, Likun Zhuang, Lizhen Chen, Mengzhen Dong, Jie Zhang, Yongning Xin |
| 185 |
[GO] |
2020―Mai―29 |
A suspected case of COVID-19 turned into a confirmed case: a case report from Iran |
Di Yang, Kai Wei, Xuesong Gao, Yijin Zhang, Ping Gao, Hongjie Li, Xiaomin Liu, Zheng Yuan, Te Xiao, Wenshan Zhao, Xuefei Duan |
| 186 |
[GO] |
2020―Mai―26 |
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise |
John Nemunaitis, Laura Stanbery, Neil Senzer |
| 187 |
[GO] |
2020―Mai―20 |
Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections |
Mona Fani, Ali Teimoori, Shokouh Ghafari |
| 188 |
[GO] |
2020―Mai―12 |
Prediction and analysis of key protein structures of 2019-nCoV |
Qihao Li, Wen Peng, Yu Ou |
| 189 |
[GO] |
2020―Apr―24 |
The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification |
Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang |
| 190 |
[GO] |
2020―Apr―17 |
Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2 |
Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang |
